Clinical Trial Update: Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Diabetic Macular Edema [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating BAT5906 compared with Lucentis for diabetic macular edema; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• BAT5906 (BAT5906)
• Lucentis (ranibizumab)

Snippet

Sponsor: Bio-Thera Solutions | Conditions: Diabetic Macular Edema (DME) | Phase 3 | Status: RECRUITING